G. D. Tarasova
Research Subjects
Research Interests
G. D. Tarasova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana I. Garashchenko
The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia; Pirogov Russian National Research Medical University
5 shared publications Moscow Scientific And Clinical Center Of Otorhinolaryngology
2 shared publications- A. S. Tulina1 shared publication
- Adnan S. Yunusov
National Medical Research Center for Otorhinolaryngology of the Federal Medical-Biological Agency
1 shared publication - E. V. Mirzabekyan
Hospital of the Russian Academy of Sciences
1 shared publication E.S. Rogova
1 shared publication
Latest Publications
- 5 June 2020
- Published by Bionika Media in Pharmateca
- Vol. 5_2020
Allergic rhinitis from the standpoint of an otorhinolaryngologist
- 5 June 2020
- Published by Bionika Media in Pharmateca
- Vol. 5_2020
Allergic rhinitis from the standpoint of an otorhinolaryngologist
- Open Access
- 27 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 22-30
This familiar diagnosis of “rhinitis”
Этот привычный диагноз «ринит»
- 27 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 22-30
Open AccessThis familiar diagnosis of “rhinitis”
Этот привычный диагноз «ринит»
- Open Access
- 22 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 85-92
Potential use of synbiotics in ENT diseases
Возможности использования синбиотика при ЛОР-заболеваниях
- 22 May 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 85-92
Open AccessPotential use of synbiotics in ENT diseases
Возможности использования синбиотика при ЛОР-заболеваниях
- Open Access
- 9 March 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 50-58
Inhaled glucocorticosteroids in otorhinolaryngology
Ингаляционные глюкокортикостероиды в оториноларингологии
- 9 March 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 50-58
Open AccessInhaled glucocorticosteroids in otorhinolaryngology
Ингаляционные глюкокортикостероиды в оториноларингологии
- 1 January 2020
- Published by LLC Polyforum Group in Russian Otorhinolaryngology
- Vol. 19 (1)
Post-viral rhinosinusitis in children: the possibilities of topical monotherapy
The results of the study of the effectiveness of monotherapy in 60 children aged 2,5 to 18 years with acute postviral rhinosinusitis (APRS) Polydexa with phenylephrinum using objective methods (nasal cavity smears on the flora and smears-prints from the nasal mucosa) are presented. Dynamic observation showed that in the course of treatment there was a rapid relief of the symptoms of the disease, the absence of pathological progression of APRS and negative phenomena. The normalization of microflora and cytological pattern in smears-prints from the nasal mucosa was also noted.
- 1 January 2020
- Published by LLC Polyforum Group in Russian Otorhinolaryngology
- Vol. 19 (1)
Post-viral rhinosinusitis in children: the possibilities of topical monotherapy
The results of the study of the effectiveness of monotherapy in 60 children aged 2,5 to 18 years with acute postviral rhinosinusitis (APRS) Polydexa with phenylephrinum using objective methods (nasal cavity smears on the flora and smears-prints from the nasal mucosa) are presented. Dynamic observation showed that in the course of treatment there was a rapid relief of the symptoms of the disease, the absence of pathological progression of APRS and negative phenomena. The normalization of microflora and cytological pattern in smears-prints from the nasal mucosa was also noted.
- Open Access
- 24 November 2019
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 192-197
Allergic rhinitis in children’s practice
Due to the prevalence of allergic rhinitis (AR) among the population of Russia, especially in pediatric practice, it is important today to give coverage to its clinical manifestations, principles of diagnosis, management of the patients and the possibilities to prevent exacerbations and increasing severity of illness. The authors provide the reasons behind why the intermittent AR has a persistent course. The article presents the diagnostic methods recommended in the ARIA documents. The authors note the important role of tight junctions in the nasal mucosa structure in protecting a person from aeroallergens and substantiate the rationality of prescribing systemic antihistamines to treat viral and a number of other types of infection. They also provide characteristics of minimal persistent inflammation and the distinctive features of local AR. According to the authors, the rationale for the use of complex treatment is the impossibility to completely cure AR. The article lists the activities and drugs included in the therapy regimen that is defined in the ARIA documents. However, the choice of a drug prescribed to the patient should be personified. The authors substantiate the prescription of systemic antihistamines in the development of acute respiratory viral infections caused by rhinovirus and give preference to Fenistil® due to the possibility of its use at an early age from 1 month in the form of syrup and drops as the most convenient dosage forms. The benefits of Fenistil® include: the speed of onset of a drug effect and its duration, high antihistamine activity and, as a result, pronounced itch relief, as well as the absence of a cardiotoxic effect, mild sedative effect, the ability of precise dosing and reduced production of nasal secretions. A clinical case with the rationale for the systemic use of this drug is presented. It is concluded that clinical data on the high efficacy and safety of Fenistil® entitle us to believe that its use is expedient, especially in pediatric practice.
- 24 November 2019
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 192-197
Open AccessAllergic rhinitis in children’s practice
Due to the prevalence of allergic rhinitis (AR) among the population of Russia, especially in pediatric practice, it is important today to give coverage to its clinical manifestations, principles of diagnosis, management of the patients and the possibilities to prevent exacerbations and increasing severity of illness. The authors provide the reasons behind why the intermittent AR has a persistent course. The article presents the diagnostic methods recommended in the ARIA documents. The authors note the important role of tight junctions in the nasal mucosa structure in protecting a person from aeroallergens and substantiate the rationality of prescribing systemic antihistamines to treat viral and a number of other types of infection. They also provide characteristics of minimal persistent inflammation and the distinctive features of local AR. According to the authors, the rationale for the use of complex treatment is the impossibility to completely cure AR. The article lists the activities and drugs included in the therapy regimen that is defined in the ARIA documents. However, the choice of a drug prescribed to the patient should be personified. The authors substantiate the prescription of systemic antihistamines in the development of acute respiratory viral infections caused by rhinovirus and give preference to Fenistil® due to the possibility of its use at an early age from 1 month in the form of syrup and drops as the most convenient dosage forms. The benefits of Fenistil® include: the speed of onset of a drug effect and its duration, high antihistamine activity and, as a result, pronounced itch relief, as well as the absence of a cardiotoxic effect, mild sedative effect, the ability of precise dosing and reduced production of nasal secretions. A clinical case with the rationale for the systemic use of this drug is presented. It is concluded that clinical data on the high efficacy and safety of Fenistil® entitle us to believe that its use is expedient, especially in pediatric practice.
- 10 April 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (2)
MONOTHERAPY OF POST-VIRAL RHINOSINUSITIS IN CHILDHOOD
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.
- 10 April 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (2)
MONOTHERAPY OF POST-VIRAL RHINOSINUSITIS IN CHILDHOOD
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.